ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,227.14
0.25%
US Tech 100
17,755.60
0.65%
다우존스 지수
39,528.31
0.36%
Bitcoin
62,596.57
-0.72%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU
  6. Valneva SE (VLA)

  7. Valneva SE (VLA) 뉴스

VLA

Valneva (VLA)

Valneva SE
일자:
정렬 기준:
 검색 관련기사 보기:EU:VLA
일자시간출처헤드라인심볼기업
2024/05/0714:00GlobeNewswire Inc.Valneva publie ses résultats financiers du premier trimestre 2024 et fait un point sur ses activitésEU:VLAValneva SE
2024/05/0714:00GlobeNewswire Inc.Valneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesEU:VLAValneva SE
2024/05/0714:00GlobeNewswire Inc.Valneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesEU:VLAValneva SE
2024/05/0614:30GlobeNewswire Inc.Déclaration d’actions et de droits de vote - 30 avril 2024 - Valneva SEEU:VLAValneva SE
2024/05/0614:30GlobeNewswire Inc.Declaration of shares and voting rights April 30, 2024 - VALNEVA SEEU:VLAValneva SE
2024/04/0501:00GlobeNewswire Inc.Déclaration d'actions et de droits de vote de la société Valneva SE - mars 2024EU:VLAValneva SE
2024/04/0501:00GlobeNewswire Inc.Declaration of voting rights - Valneva SE, March 2024EU:VLAValneva SE
2024/03/2615:00GlobeNewswire Inc.Valneva lance un essai de Phase 1 sur son candidat vaccin de deuxième génération contre le virus ZikaEU:VLAValneva SE
2024/03/2615:00GlobeNewswire Inc.Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine CandidateEU:VLAValneva SE
2024/03/2615:00GlobeNewswire Inc.Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine CandidateEU:VLAValneva SE
2024/03/2515:00GlobeNewswire Inc.Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-FEU:VLAValneva SE
2024/03/2515:00GlobeNewswire Inc.Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-FEU:VLAValneva SE
2024/03/2515:00GlobeNewswire Inc.Valneva annonce le dépôt de son Document d’Enregistrement Universel 2023 et de son rapport annuel américain « Form 20-F »EU:VLAValneva SE
2024/03/2115:00GlobeNewswire Inc.Valneva fera une présentation sur son vaccin contre le chikungunya, IXCHIQ®, et participera à plusieurs événements lors du 24ème World Vaccine Congress à Washington, D.C.EU:VLAValneva SE
2024/03/2115:00GlobeNewswire Inc.Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.EU:VLAValneva SE
2024/03/2115:00GlobeNewswire Inc.Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.EU:VLAValneva SE
2024/03/2015:00GlobeNewswire Inc.Valneva Reports Full Year 2023 Results and Provides Business Updates and OutlookEU:VLAValneva SE
2024/03/1815:00GlobeNewswire Inc.Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMedEU:VLAValneva SE
2024/03/1815:00GlobeNewswire Inc.Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMedEU:VLAValneva SE
2024/03/1815:00GlobeNewswire Inc.Valneva annonce un report de la date de début de remboursement du prêt contracté avec les sociétés Deerfield et OrbiMedEU:VLAValneva SE
2024/03/0616:30GlobeNewswire Inc.Déclaration d’actions et de droits de vote de la société Valneva - 29 février 2024EU:VLAValneva SE
2024/03/0616:30GlobeNewswire Inc.VALNEVA Declaration of shares and voting rights - February 29, 2024EU:VLAValneva SE
2024/03/0415:00GlobeNewswire Inc.Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor ConferencesEU:VLAValneva SE
2024/03/0415:00GlobeNewswire Inc.Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor ConferencesEU:VLAValneva SE
2024/03/0415:00GlobeNewswire Inc.Valneva fera une présentation lors des conférences investisseurs TD Cowen et Van Lanschot KempenEU:VLAValneva SE
2024/02/2915:00GlobeNewswire Inc.U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ®EU:VLAValneva SE
2024/02/2915:00GlobeNewswire Inc.Le Comité consultatif sur la vaccination aux États-Unis (ACIP) recommande l’utilisation d’IXCHIQ®, le vaccin à injection unique contre le chikungunya de ValnevaEU:VLAValneva SE
2024/02/2915:00GlobeNewswire Inc.U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ®EU:VLAValneva SE
2024/02/1515:00GlobeNewswire Inc.Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 GuidanceEU:VLAValneva SE
2024/02/1515:00GlobeNewswire Inc.Valneva publie son chiffre d’affaires et sa trésorerie pour l’exercice 2023 et fournit des indications préliminaires pour l’exercice 2024EU:VLAValneva SE
 검색 관련기사 보기:EU:VLA

최근 히스토리

NYSE
MRK
Merck
FX
USDJPY
US Dollar vs Yen
NASDAQ
MSFT
Microsoft
NYSE
CVX
Chevron
NYSE
DIS
Walt Disney
CCOM
SILVER
SILVER
NYSE
NKE
Nike
NYSE
JPM
JP Morgan Chase
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
COIN
ETHUSD
Ethereum
AMEX
XLE
Energy Select Sector SPDR
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유